-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JfhGeCsma/mUZa4rdvsH/terI4dDRp9GvHwAZOd0FVJaSe7Id6CpMILLcWr44HNB ndzZda4iYztdxmXs+d1xCA== 0001193125-10-050070.txt : 20100308 0001193125-10-050070.hdr.sgml : 20100308 20100308151226 ACCESSION NUMBER: 0001193125-10-050070 CONFORMED SUBMISSION TYPE: 15-12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100308 DATE AS OF CHANGE: 20100308 EFFECTIVENESS DATE: 20100308 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IMS HEALTH INC CENTRAL INDEX KEY: 0001058083 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 061506026 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-14049 FILM NUMBER: 10663521 BUSINESS ADDRESS: STREET 1: 901 MAIN AVENUE STREET 2: SUITE 612 CITY: NORWALK STATE: CT ZIP: 06851 BUSINESS PHONE: 2038455200 MAIL ADDRESS: STREET 1: 901 MAIN AVENUE STREET 2: SUITE 612 CITY: NORWALK STATE: CT ZIP: 06851 15-12B 1 d1512b.htm FORM 15 Form 15

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF

THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER

SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 001-14049

 

 

    IMS Health Incorporated    

(Exact name of registrant as specified in its charter)

 

 

901 Main Avenue

Norwalk, Connecticut 06851

(203) 845-5200

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

    Common Stock, $0.01 par value per share    

(Title of each class of securities covered by this Form)

 

 

    None    

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1)   ¨
Rule 12g-4(a)(2)   ¨
Rule 12h-3(b)(1)(i)   x
Rule 12h-3(b)(1)(ii)   ¨
Rule 15d-6   ¨

Approximate number of holders of record as of the certification or notice date: 1

Pursuant to the requirements of the Securities Exchange Act of 1934, IMS Health Incorporated has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date:        March 8, 2010          By:    /s/ DAVID R. CARLUCCI    
        

Name:  David R. Carlucci

Title:    Chief Executive Officer and President

 -----END PRIVACY-ENHANCED MESSAGE-----